The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
Scarsi
Kimberly K
KK
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, USA.
Postelnick
Michael J
MJ
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D012737:Sex Factors; D014481:United States; D016387:Women's Health
D019380:Anti-HIV Agents